Insider Trading activities of Anaptysbio Inc (ANAB)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anaptysbio Inc (ANAB) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Anaptysbio Inc since year 2005. Table 2 shows the detailed insider transactions of Anaptysbio Inc since 2005. The reporting company's ticker symbol is ANAB. The reporting company's CIK number is 1370053.
The total value of stock buying since 2005 is $24,999,990.
The total value of stock sales since 2005 is $46,432,135.
The total value of stock option exercises since 2005 is $1,091,819.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Anaptysbio Inc (ANAB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 0 $0 32,488 $2,413,022 10,060 $7,042
2019-04 0 $0 0 $0 10,000 $11,200
2019-01 0 $0 59,075 $4,163,880 59,075 $176,989
2018-12 0 $0 174,361 $12,316,374 169,363 $648,805
2018-09 0 $0 0 $0 142,857 $99,999
2018-07 0 $0 0 $0 7,636 $14,699
2018-06 0 $0 0 $0 22,428 $58,088
2018-04 0 $0 33,000 $2,879,877 0 $0
2018-02 0 $0 0 $0 16,483 $74,997
2017-08 0 $0 1,096,900 $23,757,058 0 $0
2017-07 0 $0 37,040 $901,924 0 $0
2017-01 1,666,666 $24,999,990 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Anaptysbio Inc insiders (ANAB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-10 Suria Hamza (President, CEO) Sale 22,428 74.64 1,674,025
2019-06-04 Londei Marco (Chief Medical Officer) Sale 10,060 73.46 738,997
2019-06-04 Londei Marco (Chief Medical Officer) Option Ex 10,060 .70 7,042
2019-04-17 Suria Hamza (President, CEO) Option Ex 10,000 1.12 11,200
2019-01-15 Londei Marco (Chief Medical Officer) Sale 19,075 69.66 1,328,840
2019-01-15 Londei Marco (Chief Medical Officer) Option Ex 19,075 6.93 132,189
2019-01-14 Suria Hamza (President, CEO) Sale 40,000 70.88 2,835,040
2019-01-14 Suria Hamza (President, CEO) Option Ex 40,000 1.12 44,800
2018-12-17 Londei Marco (Chief Medical Officer) Sale 30,048 66.94 2,011,563
2018-12-17 Londei Marco (Chief Medical Officer) Option Ex 30,048 3.81 114,633
2018-12-14 Suria Hamza (President, CEO) Sale 41,728 69.69 2,908,107
2018-12-14 Suria Hamza (President, CEO) Option Ex 41,728 1.12 46,735
2018-12-12 Suria Hamza (President, CEO) Sale 30,000 71.97 2,159,040
2018-12-12 Suria Hamza (President, CEO) Option Ex 30,000 1.12 33,600
2018-12-11 Suria Hamza (President, CEO) Sale 4,998 70.83 354,008
2018-12-10 Suria Hamza (President, CEO) Sale 30,587 71.52 2,187,429
2018-12-10 Suria Hamza (President, CEO) Option Ex 30,587 1.12 34,257
2018-12-03 Piscitelli Dominic (Chief Financial Officer) Sale 37,000 72.87 2,696,227
2018-12-03 Piscitelli Dominic (Chief Financial Officer) Option Ex 37,000 11.34 419,580
2018-09-07 Londei Marco (Chief Medical Officer) Option Ex 142,857 .70 99,999
2018-07-09 Suria Hamza (President, CEO) Option Ex 7,636 1.93 14,699
2018-06-08 Suria Hamza (President, CEO) Option Ex 22,428 2.59 58,088
2018-04-16 Lydon Nicholas (Director) Sale 33,000 87.27 2,879,877
2018-02-15 Lydon Nicholas (Director) Option Ex 16,483 4.55 74,997
2017-08-21 Novo Holdings A/s (10% Owner) Sale 356,300 21.10 7,518,286
2017-08-15 Novo Holdings A/s (10% Owner) Sale 143,428 21.00 3,011,988
2017-08-14 Novo Holdings A/s (10% Owner) Sale 35,172 21.79 766,503
2017-08-07 Novo Holdings A/s (10% Owner) Sale 481,023 22.01 10,586,354
2017-08-04 Novo Holdings A/s (10% Owner) Sale 10,271 22.00 225,962
2017-08-03 Novo Holdings A/s (10% Owner) Sale 21,451 22.01 472,200
2017-08-02 Novo Holdings A/s (10% Owner) Sale 25,700 23.87 613,484
2017-08-01 Novo Holdings A/s (10% Owner) Sale 23,555 23.87 562,281
2017-07-26 Tomlin Stephen Lawrence (Other) Sale 37,040 24.35 901,924
2017-01-31 Lydon Nicholas (Director) Buy 16,666 15.00 249,990
2017-01-31 Novo A/s (10% Owner) Buy 50,000 15.00 750,000
2017-01-31 Heron Patrick J (10% Owner) Buy 800,000 15.00 12,000,000
2017-01-31 Topper James N (Director) Buy 400,000 15.00 6,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of ANAB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Anaptysbio Inc (symbol ANAB, CIK number 1370053) see the Securities and Exchange Commission (SEC) website.